Provayblue 50 MG/10 ML ampule 10ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9LH3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,836
Award facts
- Contract value 100% obligated
- $15,836.19 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 15, 2026, the Defense Logistics Agency (DLA) awarded a delivery order valued at $15,836.19 to AmerisourceBergen Drug Corp for the supply of Provayblue 50 mg/10 ml ampules. This firm fixed-price contract, which carries no set-aside designation, represents a competitive award under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at up to $999.999 billion through December 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving the federal government's military and veteran healthcare systems. The work is scheduled for completion by January 16, 2026, with performance taking place at the contractor's Conshohocken facility.
AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. (formerly known as AmerisourceBergen), which holds the parent IDC with DLA for global pharmaceutical supply chain support. The DLA Medical Supply Chain utilizes this comprehensive contracting vehicle to procure a broad range of pharmaceutical products, medical supplies, vaccines, and specialized healthcare commodities required across military treatment facilities and federal healthcare systems. Delivery orders such as this one demonstrate the contractor's capability to efficiently fulfill urgent pharmaceutical procurement needs while maintaining the flexibility required to support diverse military healthcare programs worldwide.
Quick answers
Who was awarded contract SPE2DR26F9LH3?
SPE2DR26F9LH3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26F9LH3 worth?
The government has obligated $15,836 on SPE2DR26F9LH3.
Is contract SPE2DR26F9LH3 an order under another contract?
Yes. SPE2DR26F9LH3 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9LH3 competed?
The extent of competition for SPE2DR26F9LH3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award